ATE443523T1 - Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust - Google Patents

Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust

Info

Publication number
ATE443523T1
ATE443523T1 AT02742424T AT02742424T ATE443523T1 AT E443523 T1 ATE443523 T1 AT E443523T1 AT 02742424 T AT02742424 T AT 02742424T AT 02742424 T AT02742424 T AT 02742424T AT E443523 T1 ATE443523 T1 AT E443523T1
Authority
AT
Austria
Prior art keywords
rice bran
pain
mobility
loss
joint inflammation
Prior art date
Application number
AT02742424T
Other languages
English (en)
Inventor
Patricia Mcpeak
Rukmini Cheruvanky
Reddy Cherukuri
Mohammed Mazhar
Original Assignee
Nutracea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutracea filed Critical Nutracea
Application granted granted Critical
Publication of ATE443523T1 publication Critical patent/ATE443523T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT02742424T 2001-07-23 2002-07-23 Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust ATE443523T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30758801P 2001-07-23 2001-07-23
US10/012,270 US6902739B2 (en) 2001-07-23 2001-11-06 Methods for treating joint inflammation, pain, and loss of mobility
PCT/US2002/023508 WO2003009741A2 (en) 2001-07-23 2002-07-23 Methods for treating joint inflammation, pain, and loss of mobility

Publications (1)

Publication Number Publication Date
ATE443523T1 true ATE443523T1 (de) 2009-10-15

Family

ID=26683357

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742424T ATE443523T1 (de) 2001-07-23 2002-07-23 Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust

Country Status (8)

Country Link
US (3) US6902739B2 (de)
EP (1) EP1416966B1 (de)
JP (1) JP2005501043A (de)
AT (1) ATE443523T1 (de)
AU (1) AU2002315558B2 (de)
CA (1) CA2454658C (de)
DE (1) DE60233801D1 (de)
WO (1) WO2003009741A2 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
WO2003090681A2 (en) * 2002-04-24 2003-11-06 Research Development Foundation SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-κB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
EP1523318A4 (de) * 2002-06-24 2007-07-04 Res Dev Foundation Behandlung des humanen multiplen myeloms durch curcumin
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040086581A1 (en) * 2002-11-06 2004-05-06 Jones Edwin B. Bio-energetic joint and arthritis pain formula
US20040102421A1 (en) * 2002-11-21 2004-05-27 Children's Hospital Research Center At Oakland Tocopherol and tocotrienol anti-inflammatory medicaments
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
JP4596751B2 (ja) * 2003-06-11 2010-12-15 帝國製薬株式会社 消炎鎮痛貼付剤
EP1502594A1 (de) * 2003-07-31 2005-02-02 Pynogin GmbH Eine Zusammensetzung zur Minimierung des Thromboserisikos enthaltend eine Mischung von Proanthocyanidine und Sesquiterpene
JP2007503475A (ja) * 2003-08-26 2007-02-22 リサーチ ディベロップメント ファウンデーション 破骨細胞形成阻害剤およびその使用方法
WO2005032478A2 (en) * 2003-10-01 2005-04-14 Yasoo Health, Inc. Treatment for diabetic microvascular and macrovascular complications
US20080070980A1 (en) * 2004-05-18 2008-03-20 Anne Eichinger Use Of Beta-Cryptoxanthin
CA2479632C (en) * 2004-08-31 2011-07-26 Tassos Anastassiades Method for increasing the bone mineral density of a mammal using n-acylated glucosamines
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
AU2005309502B2 (en) * 2004-11-24 2011-11-17 Hill's Pet Nutrition, Inc. Methods for increasing the immune response in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
CN101107012A (zh) * 2004-11-24 2008-01-16 希尔氏宠物营养品公司 改进动物异生素物质肝清除率的方法
AU2012202194B2 (en) * 2004-12-24 2014-04-24 Dolphst Pty Ltd. Formulations and treatments for well-being
MX2007007731A (es) * 2004-12-24 2007-10-18 Dolphst Pty Ltd Formulaciones y tratamientos para el bienestar.
TWI354559B (en) * 2004-12-27 2011-12-21 Yaizu Suisankagaku Ind Co Ltd Oral disintegrative n-acetylglucosamine tablet and
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CA2784197C (en) * 2004-12-30 2015-09-01 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP4824933B2 (ja) * 2005-01-14 2011-11-30 共栄化学工業株式会社 化粧料
CA2598645A1 (en) * 2005-02-22 2006-08-31 Merial Limited Methods for selectively treating cox-2 mediated disorders by administering gamma-tocopherol
CA2600276C (en) * 2005-03-08 2013-01-08 Mitsui Norin Co., Ltd Polyphenol coxib combinations and methods
BRPI0610180A2 (pt) * 2005-05-24 2012-09-25 Wellgen Inc métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
US20080038385A1 (en) * 2006-03-13 2008-02-14 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070212470A1 (en) * 2006-03-13 2007-09-13 Nutracea Therapeutic uses of an anti-cancer composition derived from rice bran
US20070231449A1 (en) * 2006-03-30 2007-10-04 Nutracea Non-starchy rice bran polysaccharides
WO2008013219A1 (fr) * 2006-07-28 2008-01-31 Unitika Ltd. Composition orale permettant une absorption accrue de la cryptoxanthine
US20080045475A1 (en) * 2006-08-20 2008-02-21 Phillip Edward Littmann Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes
US7754256B2 (en) * 2007-03-07 2010-07-13 Stan Dennison Nutritional composition
US20090155439A1 (en) * 2007-12-14 2009-06-18 Leo Gingras Mechanical extrusion process for stabilizing cereal and oil seed bran and germ components
US20090162513A1 (en) * 2007-12-20 2009-06-25 Leo Gingras Rice hull composition
US20090162514A1 (en) * 2007-12-21 2009-06-25 Leo Gingras Production of pasta using rice bran and rice flour
US20090175967A1 (en) * 2008-01-04 2009-07-09 Nutracea Methods for treatment of intestinal carcinogenesis with rice bran
CA2718966A1 (en) * 2008-03-20 2009-09-24 Lynn Chambers Anti-inflammatory drug delivery system
EP2300030A4 (de) * 2008-05-18 2012-10-10 Rice Science Llc Reiskleienextrakt gegen entzündung und anwendungsverfahren dafür
BRPI0915337B1 (pt) * 2008-06-16 2019-09-24 N.V. Nutricia Uso de gordura vegetal, proteína e carboidrato e da fórmula líquida de leite para bebê, recipiente contendo uma fórmula líquida de leite para bebê, processo para preparar uma fórmula líquida de leite para bebê, uso da fórmula líquida de leite para bebê, fórmula líquida de leite para bebê e pó
US20100015306A1 (en) * 2008-07-15 2010-01-21 Pepsico, Inc. Method for Preparing a Low Viscosity Whole Grain Flour Slurry
MY159212A (en) 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US20100178400A1 (en) * 2009-01-13 2010-07-15 Pepsico, Inc. Method of Preparing a Whole Grain Beverage
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
JP2013515500A (ja) 2009-12-29 2013-05-09 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 炎症性の病気の改善または予防のための、ショウガが含まれる組成物
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
US8945642B2 (en) 2010-09-15 2015-02-03 Ike E. Lynch Nutritionally enhanced isolate from stabilized rice bran and method of production
US9192180B2 (en) 2010-09-15 2015-11-24 Paul Raymond Reising Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same
US20150056176A1 (en) * 2012-01-18 2015-02-26 Stanley N. Jankowitz Anti-inflammatory composition
WO2013108263A1 (en) 2012-01-18 2013-07-25 Zota Health Care Ltd Pharmaceutical formulation to reduce inflammation of bones and joint friction with improved cartilage quality
US9387218B2 (en) * 2012-04-02 2016-07-12 Eaglepharma Pty Ltd Composition for the treatment of inflammatory and immune disorders
GB201302755D0 (en) * 2013-02-15 2013-04-03 Mars Inc Horse supplement
WO2014153285A1 (en) * 2013-03-16 2014-09-25 Sinatra Stephen T Equine supplement
BR112016009351B1 (pt) 2013-11-01 2020-12-22 N.V. Nutricia Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
FR3019742A1 (fr) * 2014-04-09 2015-10-16 Lutecie Composition pour le traitement de l'hypercholesterolemie
WO2016025202A1 (en) * 2014-08-14 2016-02-18 The Regents Of The University Of Colorado Antibody-sirna conjugates and uses therefor
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
GB2546511A (en) * 2016-01-20 2017-07-26 Dodson & Horrell Ltd Horse food supplement
MY196605A (en) 2016-12-09 2023-04-20 Nutricia Nv Nutritional Composition for Improving Cell Membranes
US11090365B2 (en) 2019-08-08 2021-08-17 SVK Herbal Corporation Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129648A (en) * 1977-11-21 1978-12-12 Collier Harry O J Method for reducing endogenous prostaglandin synthesis
US4616039A (en) * 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
JPS5659710A (en) * 1979-10-22 1981-05-23 Eisai Co Ltd Preventive and remedy for psoriasis
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
JPS61286317A (ja) 1985-06-13 1986-12-16 Osaka Chem Lab 浴用剤
JPS6379834A (ja) 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
JPH04320645A (ja) 1991-04-19 1992-11-11 Tokyo Yushi Kogyo Kk 強化米ぬか油の製法
CA2124086A1 (en) * 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
US5292537A (en) 1992-11-12 1994-03-08 Bran Tec, Inc. Method for stabilizing rice bran and rice bran products
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
US5624915A (en) * 1993-08-04 1997-04-29 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5595982A (en) * 1994-03-31 1997-01-21 Harlmen Inc. Equine nutritional supplement
US5656312A (en) * 1994-09-02 1997-08-12 Erasmus; Udo Dietary food supplement and method of preparing
US5552167A (en) * 1995-05-05 1996-09-03 Nabisco, Inc. Rice bran oil antioxidant
US5709855A (en) * 1995-09-22 1998-01-20 Bockow; Barry I. Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
US6248378B1 (en) * 1998-12-16 2001-06-19 Universidad De Sevilla Enhanced food products
FR2763336B1 (fr) * 1997-05-14 1999-08-06 Lvmh Rech Esters de tocopherol et leurs utilisations en cosmetique et pharmacie
AU751704B2 (en) 1997-08-29 2002-08-22 Ricex Company, Inc., The A method for treating diabetes, hyperglycemia and hypoglycemia
US5985344A (en) 1997-09-02 1999-11-16 The Ricex Company Process for obtaining micronutrient enriched rice bran oil
WO1999011144A1 (en) 1997-09-02 1999-03-11 The Ricex Company, Inc. A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
US5972985A (en) * 1997-11-03 1999-10-26 Cytos Pharmaceuticals, Llc Histidine containing nutriceutical compositions
US5922692A (en) * 1998-03-11 1999-07-13 Marino; Richard P. Concentration of glycosaminoglycans and precursors thereto in food products
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6391864B1 (en) 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
US6217914B1 (en) 1999-03-19 2001-04-17 Bioderm, Inc. Ascorbic acid composition and method for treatment of aging or damaged skin
US6428817B1 (en) * 1999-07-06 2002-08-06 Peter Donald Collin Companion animal therapeutic treat
US6245377B1 (en) 1999-08-04 2001-06-12 Mars Incorporated Method of stabilization of rice bran by acid treatment and composition of the same
JP4585070B2 (ja) 1999-12-08 2010-11-24 丸善製薬株式会社 サイクリックａｍｐホスホジエステラーゼ阻害剤および抗アレルギー・抗炎症剤
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility

Also Published As

Publication number Publication date
US6902739B2 (en) 2005-06-07
DE60233801D1 (de) 2009-11-05
WO2003009741A3 (en) 2003-07-24
EP1416966B1 (de) 2009-09-23
US20050158406A1 (en) 2005-07-21
WO2003009741A2 (en) 2003-02-06
CA2454658C (en) 2011-10-25
CA2454658A1 (en) 2003-02-06
EP1416966A4 (de) 2005-03-02
AU2002315558B2 (en) 2007-07-05
US20030118672A1 (en) 2003-06-26
EP1416966A2 (de) 2004-05-12
JP2005501043A (ja) 2005-01-13
US20050214392A1 (en) 2005-09-29
HK1065943A1 (en) 2005-03-11

Similar Documents

Publication Publication Date Title
DE60233801D1 (de) Verfahren zur behandlung von gelenkentzündung, schmerzen und mobilitätsverlust
WO2003094836A3 (en) Methods and products for enhancing immune responses using imidazoquinoline compounds
ATE556706T1 (de) Fettalkohol-arzneimittel-konjugate
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
MXPA05006940A (es) Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
WO2002076402A3 (en) Fatty amine drug conjugates
DE60229971D1 (de) Zubereitungen zur reizhemmenden rosacea-behandlung
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
WO2004087203A3 (en) Immunostimulatory nucleic acid oil-in-water formulations for topical application
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
WO2004058164A3 (en) Asthma and allergic inflammation modulators
WO2003030934A3 (en) Cpg formulations and related methods
WO1997044063A3 (en) Dha-pharmaceutical agent conjugates
WO2005079143A3 (en) Topical formulations for the treatment of skin conditions
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
WO2005027842A3 (en) Combinations of drugs for the treatment of neoplasms
ATE318610T1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
WO2002091858A8 (en) Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
DK1343472T3 (da) Thixotropisk næsespray
DE59909607D1 (de) Tan-1057 derivate
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties